OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ivermectin: A Controversial Focal Point during the COVID-19 Pandemic
Manuel Castillejos‐López, Luz María Torres‐Espíndola, Juan Carlos Huerta­-Cruz, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1384-1384
Open Access | Times Cited: 7

Showing 7 citing articles:

Effects of topical Ivermectin on imiquimod-induced Psoriasis in mouse model – Novel findings
Sally Ayad Almudaris, Fouad Kadhim Gatea
Pharmacia (2024) Vol. 71, pp. 1-14
Open Access | Times Cited: 10

Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response
Aditi Mohan, Venkatesh Anand Iyer, Dharmender Kumar, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2121-2121
Open Access | Times Cited: 16

Public Health Needs the Public Trust: A Pandemic Retrospective
Matthew Halma, Joshua Guetzkow
BioMed (2023) Vol. 3, Iss. 2, pp. 256-271
Open Access | Times Cited: 7

A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
Desh Deepak Singh, Ihn Han, Eun Ha Choi, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 1, pp. 400-433
Open Access | Times Cited: 6

Epidemiological, clinical, therapeutic features and predictors of death among COVID-19 patients hospitalized in Parakou: a cross-sectional study in Northern Benin
Attinsounon Cossi Angelo, Yamongbè Clodel, Codjo Léopold, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5

A Twisting Tale of Misinformation: Should Ivermectin be Approved as a Treatment for COVID-19 Disease?
Arman Shafiee, Mohammad Mobin Teymouri Athar, Sayed‐Hamidreza Mozhgani
Future Virology (2023) Vol. 18, Iss. 3, pp. 137-139
Open Access | Times Cited: 4

Page 1

Scroll to top